ID   ST2B1_HUMAN             Reviewed;         365 AA.
AC   O00204; O00205; O75814;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Sulfotransferase family cytosolic 2B member 1;
DE            Short=ST2B1;
DE            Short=Sulfotransferase 2B1;
DE            EC=2.8.2.2;
DE   AltName: Full=Alcohol sulfotransferase;
DE   AltName: Full=Hydroxysteroid sulfotransferase 2;
GN   Name=SULT2B1; Synonyms=HSST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], NUCLEOTIDE SEQUENCE [MRNA]
RP   (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9799594; DOI=10.1006/geno.1998.5518;
RA   Her C., Wood T.C., Eichler E.E., Mohrenweiser H.W., Ramagli L.S.,
RA   Siciliano M.J., Weinshilboum R.M.;
RT   "Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by
RT   a single chromosome 19 gene.";
RL   Genomics 53:284-295(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND MUTAGENESIS OF 1-MET--ASP-18; 1-MET--ILE-23; ASP-19;
RP   ILE-20; SER-21; GLU-22 AND ILE-23.
RX   PubMed=12145317; DOI=10.1074/jbc.M207165200;
RA   Fuda H., Lee Y.C., Shimizu C., Javitt N.B., Strott C.A.;
RT   "Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1
RT   isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol
RT   sulfotransferase, whereas exon 1A yields pregnenolone
RT   sulfotransferase.";
RL   J. Biol. Chem. 277:36161-36166(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=16855051; DOI=10.1124/dmd.106.011114;
RA   He D., Falany C.N.;
RT   "Characterization of proline-serine-rich carboxyl terminus in human
RT   sulfotransferase 2B1b: immunogenicity, subcellular localization,
RT   kinetic properties, and phosphorylation.";
RL   Drug Metab. Dispos. 34:1749-1755(2006).
RN   [6]
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, PHOSPHORYLATION
RP   AT SER-348, AND MUTAGENESIS OF SER-347; SER-348; SER-352 AND SER-357.
RX   PubMed=21855633; DOI=10.1016/j.jsbmb.2011.07.010;
RA   Salman E.D., He D., Runge-Morris M., Kocarek T.A., Falany C.N.;
RT   "Site-directed mutagenesis of human cytosolic sulfotransferase (SULT)
RT   2B1b to phospho-mimetic Ser348Asp results in an isoform with increased
RT   catalytic activity.";
RL   J. Steroid Biochem. Mol. Biol. 127:315-323(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 19-312 IN COMPLEX WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE (PAP) AND PREGNENOLONE.
RX   PubMed=12923182; DOI=10.1074/jbc.M308312200;
RA   Lee K.A., Fuda H., Lee Y.C., Negishi M., Strott C.A., Pedersen L.C.;
RT   "Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in
RT   the presence of pregnenolone and 3'-phosphoadenosine 5'-phosphate.
RT   Rationale for specificity differences between prototypical SULT2A1 and
RT   the SULT2BG1 isoforms.";
RL   J. Biol. Chem. 278:44593-44599(2003).
CC   -!- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl
CC       sulfate (PAPS) as sulfonate donor to catalyze the sulfate
CC       conjugation of many hormones, neurotransmitters, drugs and
CC       xenobiotic compounds. Sulfonation increases the water solubility
CC       of most compounds, and therefore their renal excretion, but it can
CC       also result in bioactivation to form active metabolites. Sulfates
CC       hydroxysteroids like DHEA. Isoform 1 preferentially sulfonates
CC       cholesterol, and isoform 2 avidly sulfonates pregnenolone but not
CC       cholesterol. {ECO:0000269|PubMed:12145317,
CC       ECO:0000269|PubMed:9799594}.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + an alcohol =
CC       adenosine 3',5'-bisphosphate + an alkyl sulfate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.9 uM for DHEA (at 37 degrees Celsius, in the presence of 1
CC         mM MgCl2) {ECO:0000269|PubMed:16855051,
CC         ECO:0000269|PubMed:21855633};
CC         KM=3.8 uM for DHEA (at 37 degrees Celsius, in the presence of 10
CC         mM MgCl2) {ECO:0000269|PubMed:16855051,
CC         ECO:0000269|PubMed:21855633};
CC         KM=11.8 uM for pregnenolone (at 37 degrees Celsius, in the
CC         presence of 1 mM MgCl2) {ECO:0000269|PubMed:16855051,
CC         ECO:0000269|PubMed:21855633};
CC         KM=0.6 uM for PAPS (at 37 degrees Celsius, in the presence of 1
CC         mM MgCl2) {ECO:0000269|PubMed:16855051,
CC         ECO:0000269|PubMed:21855633};
CC         Vmax=1752 pmol/min/mg enzyme toward DHEA (at 37 degrees Celsius,
CC         in the presence of 10 mM MgCl2) {ECO:0000269|PubMed:16855051,
CC         ECO:0000269|PubMed:21855633};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius. Retains 70% and 20%
CC         of activity when incubated at 42 degrees Celsius for 45 and 120
CC         minutes, respectively. Activity is lost after 200 minutes
CC         incubation at 42 degrees Celsius. {ECO:0000269|PubMed:16855051,
CC         ECO:0000269|PubMed:21855633};
CC   -!- INTERACTION:
CC       P14621:ACYP2; NbExp=3; IntAct=EBI-749441, EBI-10198377;
CC       Q96Q35:ALS2CR12; NbExp=8; IntAct=EBI-749441, EBI-750451;
CC       Q96Q35-2:ALS2CR12; NbExp=5; IntAct=EBI-749441, EBI-11533409;
CC       O43900:PRICKLE3; NbExp=3; IntAct=EBI-749441, EBI-1751761;
CC       P50225:SULT1A1; NbExp=6; IntAct=EBI-749441, EBI-2814403;
CC       O43704:SULT1B1; NbExp=8; IntAct=EBI-749441, EBI-10179062;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Microsome. Nucleus.
CC       Note=Phosphorylation of Ser-348 is required for translocation to
CC       the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=SULT2B1b, B;
CC         IsoId=O00204-1; Sequence=Displayed;
CC       Name=2; Synonyms=SULT2B1a, A;
CC         IsoId=O00204-2; Sequence=VSP_012510;
CC   -!- TISSUE SPECIFICITY: Expressed highly in placenta, prostate and
CC       trachea and lower expression in the small intestine and lung.
CC       {ECO:0000269|PubMed:9799594}.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U92314; AAC78498.1; -; mRNA.
DR   EMBL; U92315; AAC78499.1; -; mRNA.
DR   EMBL; U92322; AAC78553.1; -; Genomic_DNA.
DR   EMBL; U92316; AAC78553.1; JOINED; Genomic_DNA.
DR   EMBL; U92318; AAC78553.1; JOINED; Genomic_DNA.
DR   EMBL; U92319; AAC78553.1; JOINED; Genomic_DNA.
DR   EMBL; U92320; AAC78553.1; JOINED; Genomic_DNA.
DR   EMBL; U92321; AAC78553.1; JOINED; Genomic_DNA.
DR   EMBL; U92322; AAC78554.1; -; Genomic_DNA.
DR   EMBL; U92316; AAC78554.1; JOINED; Genomic_DNA.
DR   EMBL; U92317; AAC78554.1; JOINED; Genomic_DNA.
DR   EMBL; U92318; AAC78554.1; JOINED; Genomic_DNA.
DR   EMBL; U92319; AAC78554.1; JOINED; Genomic_DNA.
DR   EMBL; U92320; AAC78554.1; JOINED; Genomic_DNA.
DR   EMBL; U92321; AAC78554.1; JOINED; Genomic_DNA.
DR   EMBL; AC008403; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034694; AAH34694.1; -; mRNA.
DR   CCDS; CCDS12723.1; -. [O00204-1]
DR   CCDS; CCDS12724.1; -. [O00204-2]
DR   RefSeq; NP_004596.2; NM_004605.2. [O00204-2]
DR   RefSeq; NP_814444.1; NM_177973.1. [O00204-1]
DR   UniGene; Hs.369331; -.
DR   PDB; 1Q1Q; X-ray; 2.91 A; A=24-365.
DR   PDB; 1Q1Z; X-ray; 2.40 A; A=19-312.
DR   PDB; 1Q20; X-ray; 2.30 A; A=19-312.
DR   PDB; 1Q22; X-ray; 2.50 A; A=19-312.
DR   PDBsum; 1Q1Q; -.
DR   PDBsum; 1Q1Z; -.
DR   PDBsum; 1Q20; -.
DR   PDBsum; 1Q22; -.
DR   DisProt; DP00404; -.
DR   ProteinModelPortal; O00204; -.
DR   SMR; O00204; -.
DR   BioGrid; 112689; 12.
DR   IntAct; O00204; 13.
DR   MINT; MINT-1440870; -.
DR   STRING; 9606.ENSP00000201586; -.
DR   ChEMBL; CHEMBL1743297; -.
DR   DrugBank; DB01812; Adenosine-3'-5'-Diphosphate.
DR   DrugBank; DB03309; N-Cyclohexyltaurine.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB02789; Pregnenolone.
DR   SwissLipids; SLP:000001653; -. [O00204-1]
DR   SwissLipids; SLP:000001654; -. [O00204-2]
DR   iPTMnet; O00204; -.
DR   PhosphoSitePlus; O00204; -.
DR   BioMuta; SULT2B1; -.
DR   MaxQB; O00204; -.
DR   PaxDb; O00204; -.
DR   PeptideAtlas; O00204; -.
DR   PRIDE; O00204; -.
DR   DNASU; 6820; -.
DR   Ensembl; ENST00000201586; ENSP00000201586; ENSG00000088002. [O00204-1]
DR   Ensembl; ENST00000323090; ENSP00000312880; ENSG00000088002. [O00204-2]
DR   GeneID; 6820; -.
DR   KEGG; hsa:6820; -.
DR   UCSC; uc002pjl.4; human. [O00204-1]
DR   CTD; 6820; -.
DR   DisGeNET; 6820; -.
DR   GeneCards; SULT2B1; -.
DR   HGNC; HGNC:11459; SULT2B1.
DR   HPA; CAB033013; -.
DR   HPA; HPA041724; -.
DR   HPA; HPA043539; -.
DR   MIM; 604125; gene.
DR   neXtProt; NX_O00204; -.
DR   OpenTargets; ENSG00000088002; -.
DR   PharmGKB; PA36249; -.
DR   eggNOG; KOG1584; Eukaryota.
DR   eggNOG; ENOG4111H56; LUCA.
DR   GeneTree; ENSGT00760000118932; -.
DR   HOGENOM; HOG000037209; -.
DR   HOVERGEN; HBG001195; -.
DR   InParanoid; O00204; -.
DR   KO; K01015; -.
DR   OMA; PVGIYSP; -.
DR   OrthoDB; EOG091G0D5F; -.
DR   PhylomeDB; O00204; -.
DR   TreeFam; TF321745; -.
DR   Reactome; R-HSA-156584; Cytosolic sulfonation of small molecules.
DR   EvolutionaryTrace; O00204; -.
DR   GeneWiki; SULT2B1; -.
DR   GenomeRNAi; 6820; -.
DR   PRO; PR:O00204; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000088002; -.
DR   CleanEx; HS_SULT2B1; -.
DR   Genevisible; O00204; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004027; F:alcohol sulfotransferase activity; TAS:Reactome.
DR   GO; GO:0015485; F:cholesterol binding; IDA:CAFA.
DR   GO; GO:0003676; F:nucleic acid binding; IMP:CAFA.
DR   GO; GO:1990239; F:steroid hormone binding; IMP:CAFA.
DR   GO; GO:0050294; F:steroid sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; IDA:CAFA.
DR   GO; GO:0008202; P:steroid metabolic process; IDA:UniProtKB.
DR   GO; GO:0000103; P:sulfate assimilation; IEA:Ensembl.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000863; Sulfotransferase_dom.
DR   Pfam; PF00685; Sulfotransfer_1; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Lipid metabolism; Microsome; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Steroid metabolism;
KW   Transferase.
FT   CHAIN         1    365       Sulfotransferase family cytosolic 2B
FT                                member 1.
FT                                /FTId=PRO_0000085149.
FT   NP_BIND      70     75       PAPS.
FT   NP_BIND     244    249       PAPS.
FT   NP_BIND     274    276       PAPS.
FT   COMPBIAS    305    365       Pro/Ser-rich.
FT   ACT_SITE    125    125       Proton acceptor.
FT   BINDING      98     98       Substrate.
FT   BINDING     103    103       Substrate.
FT   BINDING     125    125       Substrate.
FT   BINDING     147    147       PAPS.
FT   BINDING     155    155       PAPS.
FT   BINDING     210    210       PAPS.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000269|PubMed:21855633}.
FT   VAR_SEQ       1     23       MDGPAEPQIPGLWDTYEDDISEI -> MASPPPFH (in
FT                                isoform 2). {ECO:0000303|PubMed:9799594}.
FT                                /FTId=VSP_012510.
FT   VARIANT      51     51       L -> S (in dbSNP:rs16982149).
FT                                /FTId=VAR_020887.
FT   VARIANT     240    240       V -> I (in dbSNP:rs2302947).
FT                                /FTId=VAR_021988.
FT   VARIANT     345    345       P -> L (in dbSNP:rs17842463).
FT                                /FTId=VAR_020888.
FT   MUTAGEN       1     23       Missing: Loss of the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN       1     18       Missing: Increases the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN      19     19       D->A: Increases the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN      20     20       I->A: Loss of the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN      21     21       S->A: Increases the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN      22     22       E->A: Increases the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN      23     23       I->A: Loss of the cholesterol
FT                                sulfotransferase activity.
FT                                {ECO:0000269|PubMed:12145317}.
FT   MUTAGEN     347    347       S->A: No change in subcellular
FT                                localization.
FT                                {ECO:0000269|PubMed:21855633}.
FT   MUTAGEN     348    348       S->D: 10-fold increase in specific
FT                                activity for DHEA sulfation. 10-fold
FT                                increase in substrate affinity for DHEA
FT                                and pregnenolone. No effect on substrate
FT                                affinity for PAPS. Increases enzyme
FT                                stability. {ECO:0000269|PubMed:21855633}.
FT   MUTAGEN     348    348       S->G: Abolishes nuclear localization.
FT                                {ECO:0000269|PubMed:21855633}.
FT   MUTAGEN     352    352       S->G: No change in subcellular
FT                                localization.
FT                                {ECO:0000269|PubMed:21855633}.
FT   MUTAGEN     357    357       S->G: No change in subcellular
FT                                localization.
FT                                {ECO:0000269|PubMed:21855633}.
FT   CONFLICT    350    350       S -> N (in Ref. 1; AAC78498).
FT                                {ECO:0000305}.
FT   HELIX        19     25       {ECO:0000244|PDB:1Q20}.
FT   STRAND       31     34       {ECO:0000244|PDB:1Q20}.
FT   STRAND       37     41       {ECO:0000244|PDB:1Q20}.
FT   HELIX        46     54       {ECO:0000244|PDB:1Q20}.
FT   STRAND       63     68       {ECO:0000244|PDB:1Q20}.
FT   HELIX        73     84       {ECO:0000244|PDB:1Q20}.
FT   TURN         85     87       {ECO:0000244|PDB:1Q20}.
FT   HELIX        90     94       {ECO:0000244|PDB:1Q20}.
FT   HELIX        97    100       {ECO:0000244|PDB:1Q20}.
FT   STRAND      103    106       {ECO:0000244|PDB:1Q20}.
FT   HELIX       110    112       {ECO:0000244|PDB:1Q20}.
FT   STRAND      121    124       {ECO:0000244|PDB:1Q20}.
FT   TURN        128    130       {ECO:0000244|PDB:1Q20}.
FT   HELIX       133    135       {ECO:0000244|PDB:1Q20}.
FT   STRAND      141    146       {ECO:0000244|PDB:1Q20}.
FT   HELIX       149    162       {ECO:0000244|PDB:1Q20}.
FT   STRAND      163    166       {ECO:0000244|PDB:1Q1Z}.
FT   HELIX       172    180       {ECO:0000244|PDB:1Q20}.
FT   HELIX       189    196       {ECO:0000244|PDB:1Q20}.
FT   HELIX       197    199       {ECO:0000244|PDB:1Q20}.
FT   STRAND      205    209       {ECO:0000244|PDB:1Q20}.
FT   HELIX       210    215       {ECO:0000244|PDB:1Q20}.
FT   HELIX       217    228       {ECO:0000244|PDB:1Q20}.
FT   HELIX       234    244       {ECO:0000244|PDB:1Q20}.
FT   HELIX       246    250       {ECO:0000244|PDB:1Q20}.
FT   TURN        253    255       {ECO:0000244|PDB:1Q20}.
FT   TURN        256    259       {ECO:0000244|PDB:1Q1Z}.
FT   TURN        262    264       {ECO:0000244|PDB:1Q20}.
FT   TURN        267    269       {ECO:0000244|PDB:1Q20}.
FT   HELIX       280    283       {ECO:0000244|PDB:1Q20}.
FT   HELIX       287    300       {ECO:0000244|PDB:1Q20}.
FT   TURN        301    303       {ECO:0000244|PDB:1Q20}.
SQ   SEQUENCE   365 AA;  41308 MW;  13E95248DD40DF91 CRC64;
     MDGPAEPQIP GLWDTYEDDI SEISQKLPGE YFRYKGVPFP VGLYSLESIS LAENTQDVRD
     DDIFIITYPK SGTTWMIEII CLILKEGDPS WIRSVPIWER APWCETIVGA FSLPDQYSPR
     LMSSHLPIQI FTKAFFSSKA KVIYMGRNPR DVVVSLYHYS KIAGQLKDPG TPDQFLRDFL
     KGEVQFGSWF DHIKGWLRMK GKDNFLFITY EELQQDLQGS VERICGFLGR PLGKEALGSV
     VAHSTFSAMK ANTMSNYTLL PPSLLDHRRG AFLRKGVCGD WKNHFTVAQS EAFDRAYRKQ
     MRGMPTFPWD EDPEEDGSPD PEPSPEPEPK PSLEPNTSLE REPRPNSSPS PSPGQASETP
     HPRPS
//
